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Vaccination is one of the most cost-effective public health interventions. However, the EU is 
facing increasing outbreaks of vaccine preventable diseases, with some fatal cases of measles. 
This paper reviews the main factors influencing vaccination uptake, and assesses measures 
expected to improve vaccination coverage. Obstacles to vaccination include concerns about 
vaccine safety and side effects, lack of trust, social norms, exposure to rumours and myths, 
and access barriers. Responses fall into three broad categories. Regulation, including the 
introduction of mandatory vaccination, can be justified but it is important to be sure that it is 
an appropriate solution to the existing problem and does not risk unintended consequences. 
Facilitation involves ensuring that there is an effective vaccination programme, 
comprehensive in nature, and reducing the many barriers, in terms of cost, distance, and time, 
to achieving high levels of uptake, especially for marginalised or vulnerable populations. 
Information is crucial, but whether in the form of public information campaigns or 
interactions between health workers and target populations, must be designed very carefully 
to avoid the risk of backfire. There is no universal solution to achieving high levels of vaccine 
uptake but rather a range or combinations of options. The choice of which to adopt in each 












Vaccination is among the most cost-effective public health interventions available to prevent 
common communicable diseases. Yet, despite the availability of safe and effective vaccines 
against a growing range of infections and the existence of programmes to administer them, 
European countries continue to experience entirely preventable outbreaks, in some cases 
leading to fatalities.[1] These outbreaks often occur where there is a breakdown in herd 
immunity, whereby sufficient individuals remain susceptible to infection to allow it to spread 
within the population. It is therefore important to understand why existing programmes 
sometimes fail to achieve herd immunity. There are a number of reasons, relating to both 
supply (such as the effective organisation of the vaccination programme) and demand (such as 
vaccine hesitancy, where individuals distrust the vaccine). Consequently, the response must 
be tailored to the nature of the problem. 
Based on a report written for the European Commission,[2] we review the main factors, both 
enablers and barriers, that influence vaccination uptake and suggest measures that can be 
expected to improve vaccination coverage.   
Factors influencing vaccination coverage 
At an individual level, the decision to be vaccinated can be viewed as the outcome of the 
individual’s assessment of the benefits and costs involved. [3] Individuals will be vaccinated 
if their perceived benefits outweigh the perceived costs. Similarly, parents will vaccinate their 
children if their assessment of the benefits exceed the perceived costs of vaccination.  
Individual or child vaccination provides private benefits. By being vaccinated, an individual 
protects herself/himself (or the parent protects her/his child) against contracting disease. The 
assessment of private benefit depends on i) the health loss that is anticipated from having the 
disease and ii) the perceived risk of contracting the disease. [4]  
Individual or child immunization also generates private costs. These include monetary and 
non-monetary costs to the individual. Non-monetary costs include perceived adverse effects, 
safety concerns, discomfort, fear of injection, worries that the vaccine itself could cause the 
disease, and difficulties in accessing the vaccine provider due to distance or inconvenient or 
delayed appointments. Monetary costs include any payment for the vaccine or its 
administration, as well as costs of travel. There are also private opportunity costs related to 




However, vaccination also has social (or societal) benefits since it reduces the risk of directly 
infecting others and, as noted above, if the proportion of the population protected is above the 
herd immunity threshold, the infection is unable to spread through the population (social 
benefit).[5] This is a form of positive externality.   
Low perceived benefits and/or high costs lead to what is known as vaccine hesitancy, defined 
by a WHO working group as “the delay or refusal of vaccination despite the availability of 
vaccine services”. Key drivers of vaccine hesitancy, the so-called 3 Cs, are:[6] 
     Complacency, relating to perceived low risk from vaccine preventable diseases. This 
leads to a low value being placed on perceived benefits. 
     Low Confidence, reflecting concerns about the safety of vaccines and those who 
administer them, or lack of trust in them. Low confidence increases the private cost of 
vaccination. 
     Lack of Convenience, arising when access to services is difficult, which increases the 
private cost of vaccination.  
Importantly, benefits are delayed as protection is against possible future infection, so that 
differences in time preference come into play, and are uncertain, as not everyone who will be 
exposed to the infectious agent will become infected. Benefits for an individual are also 
difficult to define precisely, as the severity of any infection may range from mild to severe.[7]  
There are a series of issues related to social benefits. Some individuals may fail to either 
recognise or accept the social benefits that vaccination has for the rest of the community (i.e., 
the positive externality they exert on others). Some individuals may also act strategically and 
“free ride”, believing that if everyone else in the community is vaccinated, then the 
probability of an outbreak approaches to zero. [8] Such an individual will obtain the benefits 
from herd immunity but does not incur any costs or inconvenience associated with 
vaccination.  
Determinants of vaccine hesitancy can be grouped in three domains: (i) Contextual influences 
include historic, socio-cultural, environmental and political factors, and factors that relate to 
the health system, the institutions involved, and the economy; (ii) Individual and group 
influences include factors arising from personal perceptions of the vaccine or influences from 
the individual’s social or peer environment, especially in the online world; (iii) Vaccine and 
vaccination-specific issues, relating specifically to characteristics of the vaccine or the 




Vaccines often generate concerns that are distinct from those associated with other healthcare 
interventions. Individuals regularly take medicines and other treatments when they fall ill 
(sometimes with non-negligible side effects), but they do so for a purpose, to prevent, control, 
or alleviate symptoms from a condition that they know they have. Healthy individuals, in 
contrast, may be more reluctant to avoid what is an uncertain future health loss by being 
vaccinated or to otherwise act in ways that provide protective (private and social) health 
benefits.[3]  
Vaccine hesitancy in the European Union 
Rates of vaccine hesitancy vary internationally. In 2015 Larson et al reviewed data on vaccine 
confidence and hesitancy from surveys in 67 countries, including 65,819 individuals in 
total.[10] We use the same data from The State of Vaccine Confidence project but limit them 
to the 20 EU countries for which data are available in the public domain (thus, excluding 
Croatia, Estonia, Cyprus, Lithuania, Luxemburg, Hungary, Malta, and Slovakia).[10] Figures 
1 and 2 show the proportion of respondents who disagree with the following statements: 
“Vaccines are important for children to have”; “Overall I think vaccines are safe”. The 
category “disagree” combines those who “tend to disagree” and “strongly disagree”.  
Figure 1 shows that, in 15 of the 20 countries, less than 10% of respondents disagreed with 
the statement that vaccines are important for children to have, five of which had less than 5% 
disagreeing. In another 5 countries the figure was over 10%, but always below 15%. Of more 
concern, however, Figure 2 reveals large differences in the proportion of respondents who 
disagree that vaccines are safe. Only in 6 countries is this less than 10%. In 10 countries it is 
between 10% and 20%, while it is over 20% in 4 countries. Thus, although at least 85% of 
respondents in each country think that vaccines are important, vaccine safety remains a 
significant concern, affecting as many as 40% of respondents in France. Given that herd 











Figure 1 Vaccines are important for children (% response who disagree) 
 
Source: The State of Vaccine Confidence (2016) project [10] 
 
 Figure 2  Overall, I think vaccines are safe (% response who disagree) 
 
Source: The State of Vaccine Confidence (2016) project [10] 
A report by Larson et al provides more up-to-date data on changes of confidence in vaccines 
over time (between 2015 and 2018).[11] Patterns vary markedly among countries. For 




decreased in all domains in Poland. Confidence in vaccine safety also increased in Demark, 
France, Netherlands, Spain and Romania, but decreased in Sweden, Finland, Germany and the 
Czech Republic. Older (55+) and better educated citizens are more likely to hold a positive 
view of vaccination than those who are younger and less educated. 
A recent Eurobarometer report is based on fieldwork undertaken in March 2019.[12] Many of 
the questions differ from those in the earlier surveys, precluding precise comparisons but 
offering additional insights. As Figure 3 shows, while overall vaccines are seen as effective, 
over 1 person in 5 does not agree in several member states that they are effective.  
 
Figure 3  Vaccines are (definitely or probably) effective 
 




Specific factors affecting vaccination uptake  
A series of specific psychological, social, and contextual factors affect the decision to be 
vaccinated or, in the case of a parent, to have their child vaccinated. The following section 
draws substantially on the systematic review by Smith et al [13] which identifies a series of 
psychological factors that influence vaccination uptake, based on 64 studies among parents of 
children. Many relate to the perception of individual and societal costs and benefits described 
above.  We first review factors that relate to perceived costs, then those that relate to 
perceived benefits, and finally those that affect both perceived benefits and costs. 
The systematic review found that there was strong evidence for an association between 
perceived adverse effects from vaccination, either viewing the vaccine as unsafe or having 
concerns about side effects, and refusal of vaccination.  
Parental anxiety about the vaccination and fear of the illness was associated with refusal. 
Anticipating regret should the child become ill after refusing vaccination was associated with 
greater uptake. 
The view that combined vaccines or a sequence of multiple vaccines given at the same time 
overwhelm the immune system is frequently invoked as a reason for not having a child 
vaccinated. However, this view was only associated with hesitancy in one of three studies. In 
contrast, a belief that combination vaccines are harmful or ineffective was associated with 
refusal in several studies. 
Smith et al also identify some studies pointing to the importance of logistical barriers, 
including inconvenient appointments times or locations and time pressures.[13] Having to pay 
for the vaccination was associated with refusal in two of three studies. This is line with the 
systematic review by Larson et al who identifies several types of costs (financial cost, time 
and distance to provider, administrative and general accessibility) as being associated with 
lower vaccination uptake.[14]  A study comparing Italian regions found an association 
between lower vaccination rates and cuts to public health budgets.[15]  
Smith et al [13] find that there was strong evidence linking uptake and perceived 
susceptibility of the child to illness. In contrast, there was only a tenuous association with the 
perceived severity of illness, with better-designed studies finding no association. Other 
reasons included a belief that the child had already contracted the illness, that complications 





Uptake was higher where parents believed that the information available was adequate and 
helpful and less likely where they felt it was inadequate. Refusal was higher among parents 
who had greater faith in the media, who were influenced by alternative/complementary 
medicine practitioners, and perceived research findings to be important.  
Almost all studies reviewed in [13] found increased refusal among parents who had incorrect 
knowledge of the vaccination schedule and, in some, where the physician was also 
misinformed. Other factors included inadequate knowledge of the vaccine and where to get it, 
or a belief that one dose was enough. Two out of three studies found that uptake was reduced 
if parents believed that it was unimportant if a child missed a dose. 
All studies found that refusal is higher among parents who believed that vaccination was 
neither necessary nor useful or disagree with it. On the other hand, uptake was higher among 
parents who perceived vaccination to be important.  
Most studies found an association between being recommended to have their child immunised 
by a health professional, friend, or family member and an increased uptake of vaccination. 
Several studies reported parents not vaccinating their child because they had been advised 
against it, or they received no or a weak recommendation from a health professional, or 
because a health professional had a negative influence on them. 
Parents who trusted healthcare professionals were more likely to have their child vaccinated, 
whereas those who believe that healthcare professionals administer vaccines without taking 
into account the individual circumstances of the child were less likely to do so.  
The evidence that trust in government played a major role was weak. Perception that there 
was government pressure to vaccinate was not associated with uptake but belief in a 
conspiracy by government was associated with refusal. 
Two out of three studies found an association between perceived social disapproval of 
vaccination and refusal. Uptake was greater where the children of family and friends had been 
vaccinated.  
Larson et al suggest that, at least in  the EU, those with less education are less likely to be 
confident in vaccines compared with those with university education.[11]  
In summary, the perception that vaccination has adverse effects is a very common reason for 
not vaccinating. Parents were also influenced by their assessment of whether their child was 




health professionals were more likely to have their child vaccinated. Those who actively 
sought information from other sources, including the Internet and social media, were less 
likely to do so, presumably because those sources perpetuate vaccine-related myths.  
Box 1 summarises the main obstacles and enablers of vaccination uptake. 
 
Box 1.  Key obstacles and enablers of vaccination uptake 
 
Obstacles 
Concerns or fears about vaccine safety (e.g. they can cause severe diseases and side effects) 
Access issues (co-payment, availability, and distance to health facility) 
Overload of children vaccination (and parents) 
Lack of adequate information and perceived medical need  
Lack of trust towards institutions  
Social norms (family, friends, peers) 
Negative exposure to rumours and myths about vaccines in general media  
Lack of adequate encouragement (recommendation, advice) from healthcare providers 
 
Enablers 
Sources of reliable information for vaccination 
Easy access, administration and availability of services 
Building trust in institutions and providers, and confidence in vaccines 
Active involvement by doctors and healthcare providers 
Exposure to positive media messages 
 




Measures and actions that can improve vaccination coverage 
This study draws on a conceptual framework used in public health to influence the use of 
products that are harmful to health, such as tobacco or junk food.[16] To increase vaccination 
uptake, measures can be divided into those that involve regulation and legislation, for 
example mandating an action and imposing penalties for non-compliance, those that facilitate 
it, making the healthy choice the easy choice, and those that seek to change the motivation 
and intention of individuals to act through information (e.g., recommending vaccination). The 
policies that have been put in place across the European Union are presented in detail in a 
recent report [17]. 
Regulate  
Several countries have already made childhood immunisation mandatory, with school entry 
contingent on the child being immunised (with penalties for non-compliance). Australia is 
adopting a “no jab, no play” law, which places responsibility for enforcement on nursery 
schools, fining those that admit an unvaccinated child.[18] In 2019, the German Bundestag 
voted to make measles vaccination mandatory for children, with penalties including a fine of 
up to €2,500 and exclusion from nursery or school.[19]    
MacDonald and colleagues have provided a taxonomy of mandatory systems, reflecting 
differences in exemptions.[20] These range from a requirement to be immunised, but allowing 
anyone to opt out without penalty, with or without a requirement to state a personal or 
philosophical objection,  the ability to opt out conditional on the vaccine hesitant individual 
(parent) having spoken with a trained healthcare worker who explains the risk of being 
unvaccinated and engages in dialogue about concerns, to the imposition of financial penalties 
or social restrictions for those refusing immunisation. The requirement for counselling partly 
addresses the concern among those who oppose mandatory vaccination on the ground that it 
violates individual rights. It ensures that the individual, or the parent of the child, makes an 
informed decision, in the latter case consistent with the duty of the state to uphold the rights 
of the child.  
A 2016 systematic review identified 21 studies of the effectiveness of mandates for 
vaccination, 18 of which were from the USA. It concluded that mandates generally led to 
increased short-term and long-term uptake in the group to whom the mandate applies.[21] 




2017 stipulating that the number of mandatory vaccinations, for minors up to 16-years, would 
be increased from four to 10. Vaccination coverage increased between 2016 and 2017, 
ranging from 0.9% for vaccination against tetanus at 24 months to 4.4% for MMR vaccination 
at 24 months.[22]  
The available evidence on mandatory vaccination has been assembled by MacDonald and 
colleagues. [20] Overall, they find this evidence to be limited but also contextually bounded. 
Ultimately, they conclude that a decision to mandate vaccination should involve a detailed 
consideration of the nature of the problem to which a mandate is seen as a solution, other 
reasons for low uptake, the prevailing cultural context, and the risk of unintended 
consequences.  
Facilitate 
A second set of measures involves facilitating action. Getting immunised should be as easy as 
possible, removing any obstacles that exist. Administering a vaccine is only one stage in a 
complex process that should address the many elements that are necessary to optimise 
population uptake.  
A first step is to decide what vaccines to provide. Some 15–20 vaccines are listed in most 
National Vaccine Plans. Especially when faced with austerity measures, health authorities 
have to make choices about which vaccines to prioritise. Several tools have been developed to 
support prioritisation and decision-making. The US Institute of Medicine (IOM) on Ranking 
Vaccines introduced an analytical model that employed multi-criteria decision-analysis tools 
to prioritize vaccines in development, but was later tested to make “smart choices” in relation 
to different goals (e.g. eradication of disease or improvement of delivery etc.).[23]  
Frameworks supporting comprehensive evaluation provide a structured approach [24] and lay 
the basis for consistent decisions on vaccination national programmes. At the core of these 
frameworks are criteria of public health relevance (burden of disease) and vaccine 
characteristics (effectiveness, immunity length, adverse events, doses required, costs per dose, 
cost-effectiveness and feasibility).[23-26]  Decisions about prioritized vaccines have to be 
made public in a comprehensible manner, which in turn will facilitate public confidence and 
acceptability of vaccines by citizens and health professionals.[27]  
Differences among EU countries in the vaccines that are on the national schedule can create 
confusion among the public as it gives the impression of lack of consensus. There may be a 




different epidemiology) but these differences need to be articulated and explained, giving a 
rationale for improved coordination across countries.  
The various elements of a comprehensive programme were set out in an umbrella review also 
written to inform the European Commission.[28] It brings together a series of subsystems 
necessary for the effective operation of a vaccination programme, including generating and 
applying evidence, funding, enacting appropriate legislation, developing appropriate 
professional roles, registering the population, monitoring public attitudes, governing the 
system, and evaluating outcomes. The review highlighted a scarcity of high-quality evidence 
from Europe and questioned the applicability of much of the evidence from the United States. 
It did, however, highlight the importance of a comprehensive approach, with a particular 
focus on groups at risk of exclusion. This includes having an accurate population register, and 
in particular one that is up-to-date and ensures inclusion of marginalised populations, a 
system for generating and applying evidence, appropriate funding, and a system of monitoring 
uptake and, where it is less than optimal, the reasons why this is so, including public attitudes. 
[28]  
Vaccination programmes should be as accessible as possible. Accessibility can be considered 
in terms of distance, time, and cost. A vaccination facility should be near to where people live 
or work, or for children perhaps in schools. Facilities should be open at times that are 
convenient and may require operating outside normal working hours. Accessibility can also 
be improved by expanding the range of providers who administer vaccine. These do not have 
to be restricted to medically-qualified primary care providers, but can include pharmacists, 
nurses, community care providers and other qualified professionals, subject to adequate 
training. This diversity in provision is important to reach out to remote or underserviced areas 
and disadvantaged groups. Here, particular attention should be directed to groups such as 
migrants, especially those that are undocumented, and ethnic minority populations, who may 
face multiple barriers to obtaining care. The cost of being immunised should be reduced as 
low as possible or free of charge. Any positive price introduces a barrier, bringing vaccination 
coverage to even lower levels. Even if vaccination is free of charge, there may still be barriers 
related to accessing the health facility or loss of pay because of time off work. It may be 
argued there is even a case for setting negative prices, in the form of conditional cash 
transfers. However, a systematic review found no association between such financial 
incentives and vaccination uptake.[29] Moreover, offering money to people that involves a 




moral outrage.[30] There may be also scope for appropriately designed financial incentive 
schemes that encourage providers to achieve herd immunity. One example is within the 
Quality and Outcome Framework in England, which among others gave rewards for family 
practices to four separate influenza immunization rates for patients with coronary heart 
disease, chronic obstructive pulmonary disease, diabetes, and stroke, although with mixed 
success.[31]  
A vaccine programme must also leave no-one behind. Protection against vaccine preventable 
diseases will only be achieved if sufficient people are vaccinated to provide herd immunity. 
Unfortunately, in some European countries, certain vulnerable and marginalised groups are at 
risk of exclusion from vaccination programmes. For example, in many countries, Roma have 
high levels of unmet need for care in general,[32] and in particular for vaccination.[33] The 
characteristics of those who are excluded, and the reasons why they are, will vary greatly. 
However, it is essential that the scale and nature of this exclusion are understood and that 
appropriate policies to address it are implemented. 
Inform 
Communication strategies are widely seen as key to improving coverage but it will be 
important to ensure that they are carefully designed and tailored for groups who are more 
hesitant. General messaging campaigns might instead have unintended consequences.[34] 
There are at least three types of communication interventions:[7, 14] 
- Mass communication campaigns 
- Personalized communication campaigns 
- Training and educational interventions 
We examine each of these in turn. Larson et al conclude that “Traditional principles and 
practices of vaccine communication remain valid, …. However, additional emphasis should 
be placed on listening to the concerns and understanding the perceptions of the public to 
inform risk communication, and to incorporate public perspectives in planning vaccine 
policies and programmes.”[14]  Cairns et al concluded that there was a lack of explicitly 
stated theoretical underpinnings in most studies evaluating these interventions, although many 
were based on the information deficit model.[7] They argued that this should be addressed by 
formulating communication interventions that are based on stated theoretical frameworks, 
prioritising interventions that support population-scale behaviours, developing macro and 




These concerns have led to a shift from the idea that people are uninformed, and thus simply 
require information, to being misinformed or disinformed, where it is not that they lack 
information, but rather the information that they have is incorrect. Messages may be conveyed 
for purposes that have nothing to do with health, but rather as a manifestation of, or a means 
to promote, distrust in authority. A failure to appreciate the power of misinformation may lead 
traditional messages on the benefits of immunisation to backfire.[35] Table 1 summarises the 
mechanisms by which backfiring might occur.  
 
Table 1.   Backfire effects in communicating public health messages 
Backfire effect Description 
Familiarity Repeated exposure to misinformation increases familiarity, 
leading to assumption that it is true 
Overkill Multiple counterarguments to misinformation is cognitively taxing 
and may lead individuals to favour simpler explanations based on 
misinformation 
Attitude polarisation When given information that is contrary to their beliefs, 
individuals selectively recall evidence and arguments that oppose 
it, thereby reinforcing the pre-existing beliefs 
Sacred values If ideas are viewed as sacred, or part of deeply held beliefs, 
monetary incentives may create moral outrage  
Social norms Highlighting an undesirable behaviour as being frequent may 
suggest that it is socially approved 
Group directed threat Messages that criticise a particular group can strengthen group 
identity and reject arguments perceived as criticising them 
Fear appeals Messages that induce fear may trigger defensive responses 
Source: Rossen et al (2016).[35] 
 
Drawing on the review by Rossen et al we can illustrate the role of backfire with some 
examples. Skurnik et al examine that correcting a myth can, paradoxically, reinforce it among 
those whose pre-existing views are challenged.[36] Thus, parents presented with text from the 
US Centers for Disease Control correcting the myth that MMR causes autism reduced the 
level of belief in the false claims, but also reduced the intention to vaccinate their child among 




reasoning, whereby people search for information that supports their preconceived view and 
disregards anything that conflicts with it.[38]  People’s self-esteem derives from the groups 
that they identify with. If they feel that that group has been portrayed negatively, those who 
are more highly committed will seek to demonstrate a strong affiliation. This is becoming an 
issue because of the growth of networks, including on social media, adopting attitudes that are 
critical of authority. Thus, messages promoting vaccination may be seen as threatening the 
identity of the group, causing them to become more cohesive. An Australian study found that 
parents identify vaccination as a marker of parental conformity to the 'toxic practices of mass 
industrial society'.[39] 
Public health campaigns can appeal to fear, highlighting the risks of not being vaccinated. 
Fear of not being vaccinated may have declined because of the reduced incidence of vaccine 
preventable illness. Meta-analysis suggests that fear appeals are generally effective, but can 
also induce negative effects among those who are less likely to engage.[40] 
Rossen et al make several proposals to avoid messages backfiring.[35] In addressing myths, it 
is better to start by stating the facts, then introduce the myth, debunk it, and replace it with 
scientific facts. The myth should never be repeated.[41] Overkill should be avoided, as 
multiple counterarguments require more cognitive efforts. They suggest messages should 
appeal to an individual’s desire to be consistent with social norms. Finally, it may be possible 
to use fear appeals selectively, but only when designed to promote positive emotions, 
including a powerful message.[40] 
It has been suggested that promotion of understanding of the concept of community, or herd, 
immunity might improve vaccine uptake. A recent systematic review found some evidence 
that this is the case but little on the effectiveness of interventions to achieve it.[42] 
Building public confidence is likely to be crucial for achieving public trust in communities. 
Trust is built through dialogue and exchange of information and opinion.[14]  
We now consider personal communication, while noting that the issues related to messaging, 
and particularly backfire, apply equally here.  
Reminder systems targeting parents and healthcare providers have been shown to be effective 
strategies.[43, 44] Parental reminders for pre-school children can increase immunization rates 
up to 34%. Positive effects on uptake have been obtained with both generic and specific 
reminders.[43] Personalised and tailored reminders have also been shown to be effective to 




Parental trust in the provider is crucial for establishing vaccine uptake.[46-48] To increase the 
willingness of parents to consider vaccination, they need to believe their provider is motivated 
by the welfare of their child rather than an abstract public health goal. Interactions between 
health professionals and parents should recognise their concerns that may range from side 
effects to the belief that vaccines weaken the immune systems or cause autism. A non-
confrontational, participatory discussion that is personalized seems the best approach to 
improve compliance.[49] Even when parents remain hesitant, the patient-provider relationship 
needs to stay intact to convey respect, build trust, and allow for other opportunities to discuss 
immunization.[50] Face-to-face interventions are particularly effective in populations who 
lack of awareness of new or recommended vaccinations.[51]  
Finally, we turn to training and education interventions, aimed primarily at vaccine providers. 
These can be effective in increasing vaccination rates in children,[43] but this has not been 
shown for increasing influenza vaccination rates among older people.[45] This can be part of 
continuing medical education or one-off sessions, using peer support and educational 
resources.[43]  
Based on a 2011 review of the literature, Cairns et al include the following recommendations 
in relation to communication strategies [7]:  
 Vaccination advocacy: credible and trusted champions for immunisation to build 
support and trust in vaccine efficacy and safety, and raise awareness of benefits. 
 Personalised information: face-to-face exchange aimed in particular for hesitant 
groups.  
 Education and training of health care workers: pre-service and in-service training for 
health care staff to improve competencies with regard to advocacy and delivery of 
effective vaccination programmes, including expertise in communication design. 
Overall, however, several reviews have concluded that the evidence for different types of 
information campaign is very limited and what exists is largely of low quality.[52, 53]  
Policy recommendations 
Based on the framework provided in the previous section, a comprehensive approach to 
strengthening vaccine programmes should consider measures in three broad categories. 
Regulation, in the form of mandatory vaccination, can be justified, with evidence that it can 




unintended and potentially counter-productive consequences. Where it is being considered, 
there should be a detailed assessment to ensure that it is an appropriate response to the 
problems being faced by the vaccination programme, that the risk of unintended consequences 
is low, and other reasons for low uptake have been addressed. It should also take account of 
the prevailing cultural context, and its characteristics should be adapted to the existing 
circumstances. 
Facilitating uptake is essential. Getting vaccinated should be made as easy as possible. This 
requires a comprehensive program to be in place, beginning with an open and transparent 
process for deciding what vaccines should be offered, ensuring that there are enough vaccines 
available in a timely manner, and continuing with a system that combines the many different 
elements required to identify the population at risk, and to facilitate their access to facilities 
that are convenient and affordable,  
Information is important. However, it is essential that this is handled in a way that is not 
counterproductive, given the considerable risk of “backfire”. Messaging should draw on the 
growing body of psychological research on framing, ensuring that health professionals have 
appropriate training. It is particularly important that those who make decisions about being 
vaccinated, in respect either of themselves or their children, see themselves as being 
adequately involved in those decisions.[54]  
Conclusion 
Vaccination rates are decreasing in many European countries, with potentially fatal 
consequences.  Many factors contribute to this situation, among them misinformation and, in 
some cases, disinformation. There is no single solution to this problem but rather a range of 
measures that can be adopted and are not mutually exclusive. However, the choice must be 
based on a detailed understanding of the nature of the problem. 
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